Perindopril: Clinical Trials

30 trials of Perindopril, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 12 unknown, 2 withdrawn, 1 enrolling by invitation. 30 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 430Completed 12, Unknown 12, Withdrawn 2, Enrolling by invitation 1, Recruiting 1, Suspended 1, Terminated 1

Follow Perindopril: new trials by email Literature Review of Perindopril trials Research Report on Perindopril

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes
Phase 4Enrolling by invitationBaylor Research Institute642026-04-082026-10-13
Timely Recovery After Subclinical Heart Failure
Perindopril - Heart Failure, Diastolic Dysfunction
Phase 4UnknownAcademisch Ziekenhuis Maastricht1302024-03-262024-04-02
Early Treatment of ARNI on Myocardial Remodeling and Progress
sacubitril/valsartan, perindopril, Cardiopulmonary Exercise Test - Myocardial Infarction
Phase 4UnknownRenJi Hospital2802020-05-012020-04-14
Coronavirus (COVID-19) ACEi/ARB Investigation
Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19
Phase 4SuspendedNational University of Ireland, Galway, Ireland24142020-04-302020-06-30
Effect of Atorvastatin on Carotid Intima Media Thickness
Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment - Essential Hypertension, Hypercholesterolemia
Phase 4UnknownYerevan State Medical University2002020-04-152020-03-13
Precision Treatment With Angiotensin Converting Enzyme Inhibitor
genotyping and selection of renin-angiotensin system blocker, Perindopril - Hypertension
Phase 4CompletedYonsei University772019-11-062023-01-11
One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
Aspirin, Atorvastatin, Perindopril - Ischemic Heart Disease
Phase 4UnknownUniversity of Roma La Sapienza1002019-11-012019-11-05
Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome
perindopril + moxonidine - Arterial Hypertension, Metabolic Syndrome
Phase 4UnknownSergey V. Nedogoda1202019-03-112019-07-23
Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
Renin-Angiotensin (RAAS) alone, Renin-Angiotensin (RAAS) blockers in combination with Spironolactone - Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2
Phase 4UnknownJames A. Tumlin, MD722018-10-012022-10-28
Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients.
Perindopril Arginine, Zofenopril, Calcium Salt, (1(R*),2Alpha,4Alpha)-isomer - Hypertension
Phase 4CompletedYaounde Central Hospital242018-10-012020-02-05
Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients
Perindopril Arginine, Losartan Potassium - Type 2 Diabetes Mellitus
Phase 4CompletedYaounde Central Hospital232017-12-202020-01-10
Fixed Combination for Lipid and Blood Pressure Control
Atorvastatin, Amlodipine, Perindopril - Arterial Hypertension, Dyslipidemias
Phase 4WithdrawnCharles University, Czech Republic2017-09-012019-06-21
Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans
Perindopril plus Amlodipine, Perindopril plus Hydrochlorothiazide, Amlodipine plus Hydrochlorothiazide - Hypertension
Phase 4CompletedUniversity of Abuja7022017-06-072021-08-24
Once-daily Fixed Combination of Three Antihypertensive Drugs
perindopril, indapamide , amlodipine, Tripliam (perindopril, indapamide, amlodipine) - Arterial Hypertension
Phase 4UnknownUniversity of Roma La Sapienza1002016-04-012016-03-16
Low-dose Combination of Three Antihypertensive Drugs
Tripliam (perindopril, indapamide, amlodipine), Reaptan (perindopril, amlodipine) - Arterial Hypertension
Phase 4UnknownUniversity of Roma La Sapienza1002016-04-012016-03-17
NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
RAS-antagonist and beta-blocker up-to maximal dosages, RAS-antagonist and beta-blocker none or at stable dose - Heart Diseases, Diabetes Mellitus, Type 2
Phase 4RecruitingMartin Huelsmann24002016-02-012023-03-14
Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes
Perindopril Oral Tablet - Diabetes Mellitus, Type 2, Hypertension
Phase 4CompletedYaounde Central Hospital202016-02-012018-01-08
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
ACEI continuation, ACEI omission - Hypotension on Induction
Phase 4CompletedUniversity of Nebraska2912015-06-012023-09-25
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
Valsartan, Perindopril - Chronic Kidney Disease
Phase 4UnknownChinese PLA General Hospital602014-11-012014-12-02
Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
Perindopril, Telmisartan, Amlodipine - Nonalcoholic Fatty Liver Disease (NAFLD)
Phase 4UnknownNanfang Hospital, Southern Medical University1802014-08-012014-08-11

Showing 20 of 30. Sign in to see all of them.

Conditions studied

Hypertension (16)  ·  Diabetes Mellitus, Type 2 (4)  ·  Renal Insufficiency, Chronic (4)  ·  Heart Failure (2)  ·  Albuminuria (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Coronary Artery Disease (1)  ·  Coronavirus Infections (1)  ·  Diabetes Mellitus (1)  ·  Dyslipidemias (1)  ·  Essential Hypertension (1)  ·  Heart Diseases (1)  ·  Hypercholesterolemia (1)

Sponsors

University of Roma La Sapienza (3)  ·  Yaounde Central Hospital (3)  ·  Academisch Ziekenhuis Maastricht (1)  ·  Anna Posadzy-Małaczyńska (1)  ·  Baylor Research Institute (1)  ·  Cardiff University (1)  ·  Charles University, Czech Republic (1)  ·  Chinese PLA General Hospital (1)  ·  Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (1)  ·  Hospices Civils de Lyon (1)  ·  Imperial College London (1)  ·  James A. Tumlin, MD (1)  ·  Martin Huelsmann (1)  ·  Medical University of Gdansk (1)  ·  Monash University (1)

Countries

China (5)  ·  Italy (3)  ·  United Kingdom (3)  ·  United States (3)  ·  Cameroon (2)  ·  France (2)  ·  Netherlands (2)  ·  Russia (2)  ·  Spain (2)  ·  Australia (1)  ·  Austria (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Finland (1)  ·  Ireland (1)

Top investigators

Carlo Gaudio, MD (2)  ·  Bernard Geny, MD (1)  ·  Bongani Mayosi, DPhil (1)  ·  Christopher J Bulpitt, MD, FRCP (1)  ·  Giuseppe Marazzi (1)  ·  Hamayak Sisakian, MD (1)  ·  Henry Krum, MBBS FRACP PhD (1)  ·  Jason F Shiffermiller, MD, MPH (1)  ·  John William McEvoy, MBBCh MHS (1)  ·  Jun Ma, M.D,Ph.D (1)  ·  Martin Huelsmann, Doz.Dr. (1)  ·  Neil Poulter, MD, MSc (1)

Results publications

PMID 18378519, PMID 18614402, PMID 19250558, PMID 20497949, PMID 20573778, PMID 21586342, PMID 22218098, PMID 22910302, PMID 23588194, PMID 24293132, PMID 24739801, PMID 24920166, PMID 25880068, PMID 27522394, PMID 27552643, PMID 30261084, PMID 30883050, PMID 31033362, PMID 34022790, PMID 34028812, PMID 37602458, PMID 3945351, PMID 6496469, PMID 8671821

NIH funding

2005 (1), 2009 (1)